Pfizer Inc.
0
Emails
Pfizer Inc. is a global biopharmaceutical company that researches, develops, and manufactures healthcare products, including innovative medicines and vaccines, to improve patient health worldwide.
Pfizer Inc. - Pfizer Quarterly Corporate Performance - Second Quarter 2024
June 18, 2024
Event Communications
Event Communications
Pfizer Inc. - Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts
June 18, 2024
Business and Collaboration Outreach
Business and Collaboration Outreach
Pfizer Inc. - ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma
June 14, 2024
Business and Collaboration Outreach
Business and Collaboration Outreach
Pfizer Inc. - Goldman Sachs 45th Annual Global Healthcare Conference
June 3, 2024
Event Communications
Event Communications
Pfizer Inc. - Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
June 3, 2024
Business and Collaboration Outreach
Business and Collaboration Outreach
Pfizer Inc. - Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
June 1, 2024
Business and Collaboration Outreach
Business and Collaboration Outreach
Pfizer Inc. - Pfizer Announces New Chief Strategy and Innovation Officer
May 6, 2024
Business and Collaboration Outreach
Business and Collaboration Outreach
Pfizer Inc. - Pfizer Reports First-Quarter 2024 Results
May 1, 2024
Business and Collaboration Outreach
Business and Collaboration Outreach
Pfizer Inc. - First Quarter 2024 Earnings Teleconference
May 1, 2024
Business and Collaboration Outreach
Business and Collaboration Outreach
Pfizer Inc. - FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
April 29, 2024
Product Announcements
Product Announcements
Pfizer Inc. - Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting
April 29, 2024
Business and Collaboration Outreach
Business and Collaboration Outreach
Pfizer Inc. - U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
April 26, 2024
Business and Collaboration Outreach
Business and Collaboration Outreach
Pfizer Inc. - Pfizer Declares Second-Quarter 2024 Dividend
April 25, 2024
Business and Collaboration Outreach
Business and Collaboration Outreach
Pfizer Inc. - Annual Meeting of Shareholders
April 11, 2024
Business and Collaboration Outreach
Business and Collaboration Outreach
Pfizer Inc. - Pfizer Quarterly Corporate Performance - First Quarter 2024
March 20, 2024
Business and Collaboration Outreach
Business and Collaboration Outreach
Pfizer Inc. - Leerink Partners Global Biopharma Conference 2024
March 5, 2024
Event Communications
Event Communications
Pfizer Inc. - TD Cowen 44th Annual Health Care Conference
February 26, 2024
Business and Collaboration Outreach
Business and Collaboration Outreach
